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Models of Care (MoCs) are increasingly recognised as a system-level enabler to 
translate evidence for ‘what works’ into policy and, ultimately, clinical practice. 
MoCs provide a platform for a reform agenda in health systems by describing not 
only what care to deliver, but also how to deliver it. Given the enormous burden of 
disease associated with musculoskeletal (MSK) conditions, system-level (macro) 
reform is needed to drive downstream improvements in MSK healthcare – at the 
health services (meso) level and at the clinical interface (micro) level. A key challenge 
in achieving improvements in MSK healthcare is sustainable implementation of 
reform initiatives, whether they be macro, meso or micro-level in scope. In this 
Chapter, we introduce the special issue of the Journal dedicated to implementation 
of MSK MoCs. We provide a contextual background on MoCs, a synthesis of 
implementation approaches across care settings covered across the Chapters in this 
themed issued, and perspectives on evaluation of MoCs. 
 






The burden of disease of musculoskeletal conditions is a global priority. 
 
The burden of disease of musculoskeletal (MSK) conditions at a global level is well 
established, evidenced most recently through the Global Burden of Disease (GBD) 
studies where the disability burden attributed to MSK conditions was observed to be 
enormous; exceeding all non-communicable diseases (NCDs) other than mental 
health and behavioural disorders [1, 2]. These data point to the upward trajectory of 
prevalence and escalating personal and societal impacts of MSK conditions and 
persistent pain across the life course, further reinforced by recent nation-specific 
whitepapers and seminal reports [3-14]. Against a background of significantly 
reduced quality of life, function and mental wellbeing, a major human capital 
consequence of impaired MSK health, is reduced workforce participation and early 
retirement [7, 15, 16]. Reduced participation has significant downstream 
consequences for retirement wealth for the individual, and upstream consequences 
for government, such as reduced taxation revenue and increased welfare payments 
in many nations [7]. In the context of low and middle-income economies and 
subsistence communities, MSK-related disability results in reduced capacity for work 
participation and therefore a critical threat to livelihoods. Importantly, while 
communicable diseases remain a large driver to disability-adjusted life years in low 
and middle income economies, the recent GBD data point to an increasing burden of 
NCDs, particularly MSK conditions, in low and middle-economies [17, 18]. In this 
context, addressing the burden of disease for MSK conditions across economies and 
across the life course, and their unifying feature of persistent or recurrent pain, is 
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indeed an urgent global priority [19]. Lim et al (Chapter 3) explore the burden of 
disease challenges in low and middle-income Asian economies. 
 
The scale of the MSK burden and its sequelae present major challenges to which 
nations need to adequately respond. While the World Health Organisation (WHO) 
has developed an guide for nations to assess their policy and program capacity to 
respond to NCDs, the guide considers only cancer, lung diseases, diabetes and 
cardiovascular disease [20]. Similarly, the WHO 2013-2020 Global Action Plan for the 
Prevention and Control of Non-Communicable Diseases [21] focuses on 
cardiovascular diseases, cancer, chronic respiratory diseases and diabetes; although 
MSK conditions remain within its scope. Support for nations to develop and 
sustainably implement system response capacity is needed. This issue of the Journal 
tackles these challenges across different economic and care settings to provide 
readers with evidence-informed, practical guidance. 
 
Big problems need big solutions 
 
MSK health outcomes are influenced by a range of factors: health system and public 
health factors (macro-level), service delivery factors (meso-level) and clinician and 
consumer behaviours (micro-level) [19] (Table 1). These factors are discussed in 
further detail across the various chapters in this issue of the Journal. Despite a large 
volume of evidence for ‘what works’ to address MSK health impairments and their 
sequelae, these evidence-based strategies are inadequately applied in practice by 
health providers [22-25], inadequately integrated into lifestyle behaviours by health 
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consumers [26-28], and feature in health policy and health service delivery 
objectives at a level grossly incommensurate with the burden of disease [29-33]. In 
order to effectively and sustainably address the burden of disease of MSK 
conditions, a multi-level response is required, where macro, meso, and micro-level 
factors need to be considered [19]. As outlined in the various chapters in this issue of 
the Journal, a multi-level response is necessarily a complex intervention that 
demands a cross-sector, multidisciplinary and a partnerships-driven approach, 
supported where feasible, by governments. Here, Models of Care provide one 
possible vehicle to drive effective change [19, 30, 34-36].  
 
Models of Care for musculoskeletal health 
 
What are they? 
 
A MoC is an evidence-informed policy or framework that outlines the optimal 
manner in which condition-specific care should be made available and delivered to 
consumers at a systems level. A MoC aims to describe the principles of care for a 
given condition (the ‘what’), as well as guidance on how those principles could be 
implemented in a local setting (the ‘how’). MoCs aim to address current and 
projected community need in the context of local operational requirements. The 
guidance provided is coined as “the right care, delivered at the right time, by the 
right team, in the right place, with the right resources” [34]. MoCs are used as a 
facilitator to bridge the gap between evidence for what works (or doesn’t work) in 
care delivery and practice, by describing not only what to do, but critically also how 
to do it within a health system, considering the macro, meso and micro levels. Here, 
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an important distinction is that a MoC is not a clinical practice guideline. Rather, 
MoCs complement clinical practice guidelines by serving as a guide to describe how 
best-evidence for delivery of MSK care can be implemented as a sector-wide model 
of service delivery by clinicians, consumers, and health systems across the disease 
continuum, while considering practicalities of the local environment. A Model of 
Service Delivery is not the same as a MoC. A Model of Service Delivery 
operationalizes the MoC and describes in detail how a given MoC is to be 
implemented in a local setting or health service at an operational level. A Model of 
Service Delivery is therefore the next step in the implementation continuum (Figure 
1).  
 
Figure 1 Schematic of the continuum between identifying a complex health 
problem to implementing best practice care within a local setting. The 
Model of Care provides principle-level guidance on what care and 
how to implement it, while the Model of Service Delivery 
operationalizes these principles into local operational activity, 
informed by an implementation plan. 
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How are MoCs developed? 
 
The approach to developing a MoC will necessarily vary between sociocultural 
settings – what is appropriate and feasible in low-income Asian economies, for 
example, will not be the same as high-income European economies. These issues are 
considered in detail in Chapters 2 and 3. Consistent with contemporary principles of 
implementation science [37], MoCs are ideally developed using multi-stakeholder 
input, and importantly, meaningful involvement of consumers and carers, as 
highlighted in Chapter 4. These principles apply not only to developing strategies for 
MSK care, but to all NCDs and apply across sociocultural and economic settings [38]. 
The diversity and scope of the stakeholders involved will vary according to the 
clinical issue being addressed and will be further informed by how the local health 
system operates, and related political considerations. In Australia, for example, a 
centrally-coordinated Health Network model is used in some jurisdictions [34], with 
established effectiveness [39, 40]. Critically, given the increasing global attention 
towards the development and implementation of MoCs, there is a need to apply 
some level of standardisation to the development, implementation and evaluation 
of MoCs to enable benchmarking and accumulation of a comparable web of 
evidence regarding effectiveness. Indeed, this is one of the priorities of the Global 
Alliance for Musculoskeletal Health of the Bone and Joint Decade 
(http://bjdonline.org/). In this regard, an internationally-informed framework to 
support the development, implementation and evaluation of MoCs has recently 
been developed with relevant representation from high, middle and low-income 
economies [35, 41]. 
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How are Models of Care used in practice? 
 
MoCs can be used to improve MSK care outcomes at macro, meso and micro levels 
by: informing policy and health strategy priorities, resourcing and health governance 
decisions (macro factors); service design and workforce capacity building initiatives 
(meso factors); consumers’ participation in care and clinicians’ practice behaviours 
(micro factors). In this regard, the Australian experience has been positive, where a 
number of MoCs and service frameworks have been developed collaboratively [30], 
and continue to be developed, monitored and iterated across jurisdictions. These 
MoCs have been instrumental in advocating for and initiating service improvement 
programs for a range of conditions, for example persistent pain [42-46], rheumatoid 
arthritis [47], osteoarthritis [48], and secondary osteoporotic fracture prevention 
[49]. At an international level, we have recently reviewed MoCs for persistent pain, 
rheumatoid arthritis, osteoarthritis, osteoporosis and MSK injury and trauma [36], 
while Hoy et al have considered the application of MoCs in practice in low and 
middle-income economies [17]. Unlike in high-income settings, they and others [17, 
50] recommend approaching policy and program initiatives for MSK health in an 
integrated health manner that is not condition-specific. Rather than a disease-
specific or ‘vertical’ approach taken in high-income settings (e.g. Chapters 2, 8 and 
9), this integrated approach better supports whole-of-system strengthening and 
minimises threats of fragmentation and short-lived initiatives. Nonetheless, some 
condition-specific initiatives, such as the World Spine Care program (discussed 
further in Chapter 10), appear to have potential, but are notably supported by 
resources from high-income economies [51] and therefore in some contexts may not 
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align optimally with the principles of development effectiveness for longer-term 
sustainability [17]. 
Approaches to implementation of Models of Care across 
settings 
 
There is now an increasing recognition about the importance of theory-based 
implementation approaches, informed by implementation and behaviour change 
science, for the successful and sustainable delivery of health policy, programs or 
interventions. Stakeholders in MSK healthcare are fortunate that a large volume of 
evidence is now available about ‘what’ care is required to effectively manage and 
prevent MSK conditions. For example, the Cochrane Musculoskeletal and Back 
groups provide libraries of rich systematic review-level evidence on intervention 
effectiveness for MSK therapies. There is, however, a dearth of research around 
what characterises the ‘how’ for effective implementation approaches to translate 
evidence into practice [52]. In this context, in order to achieve improved MSK health 
outcomes outside research settings, a better understanding of the ‘how’ to deliver 
MSK healthcare services and align evidence with policy and practice is required. 
While MoCs provide guidance on how the right care should be delivered to people 
with MSK health conditions, further guidance on various implementation approaches 
to achieve such system-wide care delivery reforms and sustainability in local models 
of service delivery is needed.  This issue of the Journal is devoted to this topic. In this 
chapter we provide an overview of the implementation approaches used across care 




Implementation approaches across high-income economies 
 
Implementation approaches will, necessarily, vary according to setting or context 
[35]. The chapters within this themed issue of the Journal demonstrate this well, 
particularly the differences in approaches adopted in high compared with low and 
middle-income economies (Chapters 2, 3, 8 and 9) and the nuances of the 
compensation environment (Chapter 5). High income economies tend to have a 
greater capacity to plan and execute health reform at a systems level due to greater 
resourcing, more stable governance arrangements and delineation across 
components of the health systems, population health surveillance capabilities, and 
more human capacity to undertake policy development and implementation within 
relatively stable political systems. This greater capacity, however, is sometimes 
offset with less agility to enact change at a local level, particularly in highly regulated 
care settings like the compensation environment, as discussed in detail by Beales et 
al (Chapter 5). Key drivers of implementation successes of MoCs in high-income 
economies seem to be based on a foundation of health policy that articulates with 
the MoC, thereby providing a platform for coordinated action by government and 
other organisations. Such policies might include chronic disease management 
frameworks, primary prevention frameworks, care integration strategies, workforce 
capacity building and role delineation plans, and so on, and directly enable 
implementation of components of MoCs. Mitchell et al (Chapter 9) provide a 
comprehensive commentary on these issues as they relate to fracture liaison 
services for secondary osteoporotic fracture management and orthogeriatric 
services while Allen et al (Chapter 8) provide a comprehensive commentary as it 
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relates to osteoarthritis care. On a background of this system-based policy, high-
income economies often have capacity to establish pilot studies or undertake 
formative evaluations of MoCs. Often, these health service, pragmatic evaluations of 
implementation stem from primary efficacy studies such as randomised controlled 
trials (RCTs). Translation of RCT findings into an up-scaled, real-world, health services 
implementation initiative appears to be an effective approach to implementation of 
MoCs in high-income settings. Dziedzic et al (Chapter 2) provide examples of this 
approach as they relate to osteoarthritis and low back pain care in the United 
Kingdom. Such up-scaling, however, demands a theory-driven approach to 
implementation or behaviour change, such as that captured by the Consolidated 
Framework for Implementation Research (CFIR) [53] or the Behaviour Change Wheel 
[54]. Beales et al (Chapter 5) describe the application of the CFIR in practice. 
  
A critical aspect of implementation in these settings is purposeful and thorough 
cross-sector engagement consultation of a range of stakeholders (e.g. clinicians, 
consumers, carers, policy makers, insurers, non-government organisations) and the 
support of clinician champions. The latter support may be provided through non-
government organisations, research groups, government bodies or professional 
bodies. No matter what the support mode, coordination and support from a central 
agency is critical [40]. This concept of central agency support extends beyond single 
jurisdictions. For example, the highly successful and global approach to fragility 
fracture care, Capture the Fracture ®, has been facilitated through the development 
and promotion of a Best Practice Framework which articulates standards for 
Fracture Liaison Services and benchmarks international services [55]. The 
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International Osteoporosis Foundation supports the program, the Best Practice 
Framework and an international program committee evaluate health services and 
support implementation of care standards (refer to Chapter 9 for further detail).  
 
Implementation approaches in high-income settings must be coupled with 
evaluation, ensuring that outcomes are meaningful to system administrators and 
consumers, which requires measurement of both system-based (e.g. economic) and 
patient-reported (e.g. function) outcomes. At a service delivery level in high-income 
settings, MSK disease MoCs need to be better aligned with a contemporary 
understanding of pain biology and better articulate the need for care integration 
given the common co-morbidities associated with MSK pain, including mental health 
conditions such as depression and anxiety [56-58]. All too often, these areas of care 
are considered disparately (for example in osteoarthritis care), rather than 
integrated, leaving service fragmented and consumers failing to receive holistic, 
best-practice care. Both Beales et al (Chapter 5) and Allen et al (Chapter 8) discuss 
this barrier to best-practice pain co-care in the contexts of compensable 
musculoskeletal injuries and osteoarthritis care, respectively. 
 
Implementation approaches in low- and middle-income settings in Asia  
 
Care of MSK conditions in Asian low- and middle-income countries is severely limited 
by significant lack of funding resources and specialty-trained workforce capacity. 
Prioritisation of government healthcare funding is generally directed towards 
communicable diseases and other NCDs associated with higher mortality, such as 
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cardiovascular diseases, diabetes mellitus and cancer. MSK conditions represent a 
low healthcare priority and there is a lack of awareness of the increasing disease 
burden and cost to the economy. Scarce resources have resulted in government 
policies focusing on primary care and prevention of these diseases, often with little 
or no integration with specialist care. Whilst there have been no specific MoCs for 
MSK conditions developed in these countries, in Chapter 3, Lim et al. provide 
examples of approaches to overcome some of these barriers. Through the 
Community Oriented Program for Control of Rheumatic Diseases (COPCORD) project, 
epidemiological data have been gathered on the burden of pain, arthritis and 
disability in developing economies, through community surveys in rural areas (see 
http://copcord.org/publications.asp and Chapter 3). The COPCORD project, in 
particular, has helped to identify the magnitude of the burden for MSK conditions in 
these countries. In the Philippines, a low-income country, the Applied Rheumatology 
Made Simple (ARMS) programme is an educational programme developed by local 
specialist societies and funded by non-government organisations (an international 
specialist society and a pharmaceutical company) that has successfully built medical 
workforce capacity. This was achieved through education of primary care providers 
on MSK conditions and developing a shared-care model together with specialists 
from local clinical networks. The programme has also added workforce capacity 
through training of patients to be educators of their own diseases. More detail is 
provided in Chapter 3. In Malaysia, a middle-income country, a different approach to 
workforce capacity building has been taken through partnership of the Ministry of 
Health with specialist societies. For example, the osteoarthritis clinical practice 
guidelines were developed by the Malaysian Society of Rheumatology and 
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workshops to upskill regional and rural medical staff are conducted with active 
support by the Ministry of Health through endorsement, logistical support and 
funding. Both the Filipino ARMS program and Malaysian osteoarthritis clinical 
practice guidelines workshops highlight the critical importance of partnerships 
between government, private funders and other special interest groups in order to 
improve care for MSK conditions. Furthermore, government recognition and 
prioritisation of MSK conditions is a key factor for developing appropriate MoCs.  
However, evaluation of the efficacy of these programmes in improving patient 
outcomes is limited to participants’ pre- and post- course knowledge. A system-wide 
evaluation of clinical practice standards would require further resources, which may 
not be feasible in low- to middle-income countries.  Hoy et al. advocate a multi-
pronged approach to the development of MSK MoCs to ensure effectiveness of 
these initiatives [17]. This approach involves: 
 active ownership and participation by local communities [59];  
 alignment of MSK MoC initiatives with existing priorities and policies such as 
national health strategies;  
 harnessing research, information and evidence to inform MoC development 
and implementation;  
 inclusion of performance indicators to monitor and evaluate the MoCs [60];  
 integration of MoCs across existing health systems;  
 financial transparency and accountability related to development and 
implementation of MoCs with organisational and funding partners;  
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 informing and engaging policymakers and leaders to develop and implement 
policies and legislation for the prevention of and management of MSK 
conditions and injuries; and  
 appropriate resource allocation for MSK MoCs (development, 
implementation and evaluation components) [61, 62].   
To ensure sustainability of these initiatives, local “champions” of MSK MoC 
implementation are required, consistent with the approach in high-income settings. 
These could include individuals involved in the education and mentoring of trainees, 
as well as those involved in research to develop a research agenda appropriate to 
local conditions. 
 
Building capacity to support implementation of Models of Care 
 
Two priority foci of building capacity to support implementation of MoCs are 
consumer involvement and an appropriately skilled health workforce. A key lever to 
support both these foci is the use of digital technologies which can reach across care 
settings and bypass care disparities imposed by geography, sociocultural factors and 
economies. Such technologies therefore play a very important role in supporting 
system-wide implementation.  
Consumer involvement 
 
Harnessing consumer involvement to support implementation is an intuitive 
corollary of actively engaging consumers in the development of MoCs. This 
involvement extends to decisions about their care, how health services and systems 
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are designed, and delivered to empower consumers and achieve improved health 
outcomes, all factors consistent with WHO recommendations for consumer-centred 
healthcare [63].  
 
In Chapter 4 of this edition, Walsh and colleagues specifically tackle the ‘how to’ 
harness consumer involvement and present an elegant evidence-synthesis and 
commentary relevant across health system levels (macro, meso and micro) [64]. 
Walsh and colleagues report that the current available evidence is primarily focused 
at the micro level and typically of a lower quality, with evidence lacking at the meso- 
and macro-levels. While they advocate ‘no one size fits all’ for adopting consumer 
involvement in MoCs, various options are presented to show how these may be 
adapted for use in low- and middle-income economies, or best suit high-income 
economies.  
 
Consumer involvement strategies can extend from representation on MoC working 
groups, to stakeholder forums, workshops, and opportunities to provide feedback on 
draft MoC documents, as well as informing specific decisions about their care needs 
[30]. Macro-level initiatives can provide guidance for consumer involvement, for 
example the National Institute for Health and Care Excellence (NICE: 
www.nice.org.uk), while agencies like the Cochrane Consumer Network 
(www.consumers.cochrane.org) provide guidance to consumers and researchers on 
ways to increase consumer-oriented research. In Australia, the use of networks such 
as the New South Wales Agency for Clinical Innovation Musculoskeletal Network 
(https://www.aci.health.nsw.gov.au/networks/musculoskeletal) and the Western 
 
 17 
Australian Musculoskeletal Network 
(http://www.healthnetworks.health.wa.gov.au/network/musculoskeletal.cfm) have 
also been effective in engaging consumers as a standard part of MoC development 
including for osteoarthritis, elective joint replacement, inflammatory arthritis, 
paediatric rheumatology, low back pain and osteoporosis [34, 65]. There are 
however, still many unmet needs, according to two recent needs analyses 
undertaken in Australia of consumers with MSK conditions [58, 66]. Both reports 
highlight the importance of harnessing engagement of target consumer groups when 
informing MoC development to ensure their needs are met and empower 
consumers to support implementation. 
 
Appropriately skilled health workforce 
 
Effective implementation of MoCs requires an appropriately skilled health 
workforce. In a comprehensive review of MoCs, we have previously described the 
evidence for what works in building capacity, flexibility and sustainability in the 
current and emerging health workforce [19, 36]. Models of education that prepare a 
‘fit for purpose’ workforce are required if we are to meet the escalating needs 
associated with MSK conditions. Given that co- and multi-morbidities are commonly 
associated with MSK conditions [2], interprofessional educational frameworks need 
to resonate with chronic disease condition frameworks [67], in order to develop the 
requisite knowledge, skills and competencies to support effective multidisciplinary 
health care over the life course [68]. In Chapter 10, Chehade and colleagues 
comprehensively interrogate the ‘how’ regarding the development and delivery of 
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integrated, collaborative interprofessional education models necessary to support 
quality, efficient and sustainable MSK MoCs across care settings. Current global 
health workforce needs, trends and challenges are examined, highlighting the 
deficiencies and care disparities imposed by geography, socio-politic and economic 
factors. For example, Chehade and colleagues describe how initiatives such as World 
Spine Care (WSC) [51], have supported a programme to address spinal pain in 
collaboration with the Botswana government and local communities. This initiative 
helps train local providers, thereby facilitating capacity building of the local health 
workforce to support spinal care MoCs. In Kenya, another capacity building initiative 
involves MSK first-line assessment and provision of a standardised programme 
delivered by physicians partnering with consumers who have themselves 
experienced a MSK condition.  
 
Initiatives to develop national standards based on MSK core competencies such as 
the Australian Musculoskeletal Education Collaboration (AMSEC), also help support 
implementation by engaging national multidisciplinary and multi-profession 
collaboration with educational institutions, consumers and government [69, 70]. 
Chehade and colleagues argue that such frameworks support reflective practice by 
providing a shared language between educators, learners and consumers to make 
sense of health experiences, thereby strengthening health workforce efforts to 
sustain MoCs. Such collaborative models better support consumer-centred care and 
provide greater efficiency and improved outcomes, both key recommendations of 




Previously, we have also described how extended scope practice across health 
professions can support effective implementation [36]. Chehade and colleagues 
extend this analysis by examining and discussing the critical role of flexible, funding 
models designed to sustain health workforce capacity building and support effective 
implementation of MoCs. For example, rheumatology nurses and rehabilitation 
professionals undertaking monitoring roles; in nurse specialists and nurse 
practitioners performing examinations, recommending medication changes and 
undertaking referrals to other health professionals; and physiotherapists triaging 
care of MSK patients, administering injections and requesting investigations.  
 
Building capacity in the health workforce is also necessary to support different care 
requirements across the life course. In Chapter 6, Stinson and colleagues present a 
comprehensive overview of contemporary MSK MoCs for paediatric-specific 
populations, emphasising that children and adolescents with chronic MSK pain 
should not be viewed as “little adults,” as developmental differences mean that age-
specific MoCs are needed. Stinson and colleagues, discuss the lack of confidence 
reported by primary care clinicians in their paediatric-MSK clinical skills, with 
unnecessary on-referrals and delays in triaging children to appropriate 
subspecialists, and outline how an interprofessional health workforce can be 
upskilled to support effective implementation of paediatric MoCs. A recent study we 
have undertaken in young 16-25 year old Australians with persistent MSK pain, 
further strengthens this concept, with young people clearly articulating an absence 
of age-appropriate health services and an appropriately skilled health workforce to 
support those services [58].  
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Harnessing eHealth technologies to build capacity 
 
EHealth is a part of the contemporary health landscape and is a critical enabler to 
implementation of accessible, sustainable and integrated MSK MoCs. Based on 
findings of the third global survey on eHealth 2015, the Atlas of eHealth country 
profiles has been developed to provide a snapshot of member states capacity to 
implement eHealth systems [71]. The use of eHealth as a mechanism to support 
implementation of MoCs is intuitive, given the capacity to up-scale effective 
technologies, to lever system and economic efficiencies, to contribute to 
sustainability, to adapt to low-resource settings and to mitigate access and care 
disparities [72, 73]. In Chapter 7, Slater and colleagues focus on the practical 
application of eHealth technologies across care settings to those MSK conditions 
contributing most substantially to the burden of disease, including osteoarthritis and 
inflammatory arthritis, skeletal fragility-associated conditions and persistent MSK 
pain.  
 
At a macro level, the use of eHealth registries and central intake systems allow for 
efficient triaging and direction to appropriate clinical pathways with ongoing 
monitoring to ensure consumers receive the right care [74]. To match the escalating 
burden of MSK conditions, eHealth-enabled centralised referral systems in public 
healthcare settings will become even more important, to ensure timely access to 
appropriate care and to optimise service delivery efficiencies. Systems that offer 
standardised, efficient data entry, monitoring and management for end users, and 
also collect both clinical and patient-reported outcomes are necessary to address 
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such important public health issues. To date, this has been difficult to achieve, but 
recent initiatives such as the launch of The Swedish Fracture Registry, providing 
population-based data on fracture management in combination with patient-
reported health outcomes, support the evaluation of system-wide MoCs for skeletal 
health [75]. Similar electronic systems for data capture, monitoring, and evaluation 
exist for persistent MSK pain. The electronic Persistent Pain Outcomes initiative 
(ePPOC), enables a systemised approach to electronic collection of a standard set of 
data items and assessment tools by specialist pain services throughout Australia and 
New Zealand and capture of person-centred and system outcomes in response to 
treatment [76]. In the United States of America, the Collaborative Health Outcomes 
Information Registry (CHOIR) system (https://choir.stanford.edu/implementation/) is 
an open source, free data-collection software created in partnership with cross-
discipline scientists, clinical experts and the National Institutes of Health and allows 
clinicians to capture qualitative information from people with pain in a safe, secure, 
and easy-to-use system. Such systems will allow cross-jurisdictional comparison of 
treatment outcomes and clinical pathways, allowing for benchmarking of practice 
and economic analysis of cost effectiveness of MSK pain treatments. 
 
eHealth systems can also facilitate building workforce capacity. For example, the 
TelePain Initiative has been implemented in Washington State, Wyoming, Alaska, 
Montana, and Idaho (USA), and uses video, web, and telephone conferencing 
technologies to bridge the gap in community needs for pain services [77]. Specific 
challenges (systems, clinician and patient, time and cost) highlight the critical role for 
strong cross-sector engagement as a cornerstone of successful implementation. In 
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low-income economies, partnership initiatives like the Telemedicine network, 
developed in Switzerland, can be used to scale up health professional education [73].  
This initiative uses a suite of software tools specifically designed to work in low-
bandwidth, low-infrastructure settings, to provide eLearning/mLearning distance 
education and tele-expertise consultations. This eHealth solution is suitable for rural, 
primary, secondary and tertiary care settings and has been implemented in areas of 
Africa, Bolivia and Laos.  
 
For consumers, eHealth systems offer implementation support for MoC through a 
wide range of eHealth applications that aim to provide health information plus social 
support, decision support, and behaviour change support [74, 78]. In Chapter 7, 
Slater and colleagues demonstrate how advances in technologies have enabled real-
time mobility and movement monitoring in natural settings [79], and how Internet-
based treatment programs can support self-management of arthritis [80], bone 
health, and persistent MSK pain for adults [81] and for young people [82]. Online 
resources such as painHEALTH (http://painhealth.csse.uwa.edu.au/) and the Pain 
Tool Kit (http://www.paintoolkit.org/), offer free 24/7 access to practical knowledge 
and skills to support best practice pain co-care. Social media tools are another key 
driver of engaged and empowered patients taking a greater role in their own health 
care [83, 84]. Furthermore, the use of mHealth applications is transforming the 
health landscape. Young people in particular, many of whom are ‘digital natives’ 
indicate their preference for access to health services and resources is via eHealth 
and mHealth technologies [58], although this is not necessarily universal [85]. While 
the evidence of effectiveness lags behind the application of technology to health, it 
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is clear that health systems will need to catch up, as technology continues to gain 
momentum. This rapid pace of change is exciting and creates new opportunities for 
better supporting implementation of MoCs across care settings and the life course, 
while concurrently highlighting the critical need for implementation science research 
in this nascent area. 
 
Evaluating Models of Care for sustainable system reform 
 
All current indications suggest that MoCs for the planning and delivery of evidence-
informed and consumer-centred healthcare are here to stay in high-, middle- and 
low-income economies [17, 19, 30, 34, 36, 51, 86-88]. The Australian experience 
highlights that while MoCs offer improved consumer pathways of care (inclusive of 
experiences, satisfaction, access, safety and appropriateness) and system 
efficiencies, there remain significant challenges associated with sustainable 
implementation [65, 89]. This situation is anecdotally mirrored in other nations, as 
highlighted across the chapters in this issue of the Journal. There is an urgent need 
to optimise implementation approaches for MoCs. Continuous evaluation and 
monitoring of the outcomes of MoCs is critical to justify the resourcing and change 
processes required to support their integration into the highly complex, political and 
dynamic health landscape in a manner that is meaningful to decision makers [86, 90, 
91].  
 
Indeed, evaluation is a strategic priority of the Global Alliance for Musculoskeletal 
Health. Evaluation approaches for MoCs can be considered as a hierarchy (Figure 2). 
 
 24 
Evaluation can be undertaken at the level of specific components of MoCs (e.g. 
strategies to build workforce capacity in skills and knowledge to deliver best MSK 
care [43, 45, 47]); evaluation of implementation of MoCs at a system-wide 
programmatic level (e.g. an osteoarthritis care program [48]); and the evaluation of 
MoCs at a system-wide level (e.g. influences on policy, funding decisions, resourcing 
decisions [89]). The majority of evaluation is targeted at the specific component 
level, since research questions are much simpler to answer at this level. 
Comparatively less work has been done at the systems level, largely because this 
level of evaluation requires significant resourcing contributions from administrative 
organisations, like Government, and evaluations take much longer to undertake and 
are inherently more complex. We suggest, however, that the impact and influence of 
system-wide or system-relevant evaluations are potentially far greater than 
component-level evaluations. Future evaluative work is therefore likely to be 
targeted more at the system level and will be facilitated through inter-agency 
partnership models and further accessibility to, and development of, linked data 




Figure 2 Evaluation hierarchy for Models of Care. The potential impact and 
influence of evaluation outcomes increases with higher evaluation 
levels. 
 
Ensuring effective implementation: readiness and success 
 
As global momentum builds in the development of MoCs for NCDs, there is an 
increasingly important rationale to; i) develop strategies to optimise development 
efforts to ensure successful implementation, and ii) to support a standardised 
approach to outcomes evaluation. This will enable comparisons between various 
MoCs in order to generate a web of evidence meaningful to end users, and also 
allow the sharing and benchmarking of comparable outcomes between jurisdictions 




A recent, large qualitative study provides primary evidence concerning the critical 
importance of appropriate evaluation of MoCs to i) optimise the chances of 
successful and sustainable implementation (‘readiness evaluation’) and ii) deliver 
meaningful indicators of implementation success (‘success evaluation’) [86]. 
Whereas the concept of success evaluation was well recognised and largely 
considered implicit as part of health system performance evaluation and quality 
improvement, the concept of readiness evaluation was considered far less well 
recognised. Readiness evaluation was found to be urgently needed, reflective of an 
appetite and expectation for deterministic and evaluative implementation 
approaches [92]. Further, these perceptions most likely reflect experiences of failed 
implementation beyond pilot studies and align with an emerging body of literature 
that now points to the need to assess organisational readiness for change in 
healthcare [37]. This is particularly so for chronic disease MoCs [94], and particularly 
relevant in primary care settings where the majority of MSK healthcare is delivered 
[37]. This approach to readiness assessment is not a new concept. Indeed, it is 
entrenched in the business sector. Here, it is considered a standard approach to 
business improvement and change management [95], embedded within 
contemporary implementation frameworks [92] and importantly, identified as a 
critical driver of evidence-practice gaps [37].  
 
The need for outcomes (success) evaluation that considers consumer (i.e. patient 
reported), as well as system outcomes, is also apparent. While MoCs are necessarily 
jurisdictionally or nationally-specific, there is considerable risk of duplication in 
efforts when outcomes and experiences from MoCs, implemented in culturally and 
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socially similar contexts, are not shared. A level of standardisation is also important 
to ensure that evaluation endeavours produce outcomes that are meaningful to 
health decision makers. 
 
System-relevant evaluation outcomes: the importance of health economics 
 
Evaluation efforts around MoCs must consider outcomes that are meaningful to end-
users. Patient-reported outcomes are essential in order to judge quality, 
effectiveness, safety and satisfaction of care. In this context, there are many well-
validated standard sets of outcome measures available, such as those recommended 
by the International Consortium for Health Outcomes Measurement (ICHOM) or the 
Patient-Reported Outcomes Measurement Information System 
(PROMIS).  System-relevant outcomes are also important for making decisions about 
system change, particularly related to the economics of health service delivery. Since 
questions around resourcing implications and potential savings and cost 
effectiveness are of critical importance in health decision-making, system-wide 
evaluations are, necessarily informed largely by economic modelling. While the cost 
modelling of specific service change initiatives (i.e. a model of service delivery), such 
as a workforce role change [96], is important at a local service level, the broader 
system implications are not necessarily considered. Real cost calculations, 
undertaken retrospectively, are equally important for accurately assessing the status 
quo and observed trends prior to the introduction of system-level change: here the 
data may inform a rationale for change. A recent example is costing hospital care for 
osteoporotic fractures in Western Australia over the last 10 years, using linked data 
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systems [97]. Cost predictions at a systems level will also be critical to informing 
decisions about implementation of MoCs. For example, recent work by Ackerman et 
al [6] and Schofield et al [7] and based on the Arthritis, Diet and Activity Promotion 
Trial (ADAPT), estimated the health and broader economic benefits likely to be 
gained by implementation of a conservative care program for Australians with 
severe knee osteoarthritis [98]. They identified that hospital resource savings from 
avoiding or delaying knee joint replacement surgery would increase from $170 
million in 2015 to over $233 million in 2030 based on 2015/16 Australian dollars [6]. 
The broader economic benefit of increased labour force participation from such 
conservative management of knee osteoarthritis in 15-64 year old Australians from 
2015 to 2030, would be an increase in annual income from $20.8 million to $33.5 
million. In 2015, there would be a saving of $7.8 million in welfare payments 
(increasing to $9.9 million in 2030) and an increase of $5.4 million in taxation 
revenue (increasing to $8.4 million in 2030) [7]. These broader system implications 
have significant value to government when developing and iterating contemporary 
policy frameworks. 
 
An internationally applicable approach to implementation 
 
Recently, an internationally-applicable approach to the development and evaluation 
of MSK MoCs has been developed [35, 41]. While the development of this 
Framework was grounded in MSK health, feasibly it could be applied to other chronic 
NCDs. Having been widely informed by stakeholders from 30 nations, the Framework 
is adaptable across settings in low, middle and high-income economies. The 
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Framework provides nations with an approach to guide development, 
implementation and evaluation of local MSK MoCs; considered a major priority 
across all nations [2, 17-19]. 
 
Applicability across nations is important. For this to be realised in practice, the 
Framework needs to articulate with established national health system development 
and evaluation approaches. In this context, the Framework aligns with the principles 
of Development Effectiveness, which are critical to health system reform initiatives 
in low and middle-income settings [17]. The Framework also aligns to healthcare 
quality dimensions applicable to high-income economies, such the Health Quality 
Council of Albert Quality Matrix (http://hqca.ca/about/how-we-work/the-alberta-




At a disease-specific level, the Framework supports the adoption of consumer-
centred Standards of Care for MSK conditions, such as those developed by the 
eumusc.net initiative [99, 100] and local, disease-specific system performance 
indicators [74, 101]. The articulation between the Framework, MoCs and these other 
guiding resources is illustrated in Figure 3. Further validating its components and use 
as a contemporary framework for evaluating development and implementation of 
MoCs, the Framework also aligns with contemporary generic implementation 






Figure 3 Schematic of where the Framework sits in relation to international 
and national health system guides and local/regional MoCs. WHO = 




Models of Care are increasingly recognised as a system enabler for improving the 
planning and delivery of health services for NCDs, especially MSK conditions, by 
translating evidence into practical guidance. Sustainable implementation of MSK 
MoCs is important to realise improvements in population MSK health, improved 
health service delivery for people who live with chronic MSK conditions, and greater 
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system efficiencies. Implementation science is, therefore, fundamental to improving 
implementation initiatives. This issue of the Journal is discusses the ‘how to’ of 
implementation for MSK MoCs across conditions and care settings. Cornerstones to 
effective implementation include sustained cross-sector engagement, support for 
clinical and administrative champions, alignment with existing health policy and 
system frameworks, and evaluating implementation efforts with consideration of 
patient-reported and system-relevant outcomes. 
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Table 1. A multi-level approach to addressing the burden of musculoskeletal (MSK) conditions, adapted from Briggs et al [19] (with 
permission from Oxford University Press).  
System level 
factors 
Determinants of musculoskeletal (MSK) health 
Macro 
The macro level considers the functionality and scope of health systems or organisations, health policy, infrastructure 
and resource allocation, and socioeconomic factors.  Health systems/organisations and their governance through 
health policy play a critical role in the planning and delivery of MSK healthcare for older people.  Healthcare systems in 
developed nations are usually oriented towards acute care services and respond to mortality risk rather than long-
term morbidity associated with MSK conditions and their co-morbidities which stymies opportunities for service 
development in ambulatory and primary care – arguably, the setting where MSK healthcare is most needed. Given the 
MSK conditions are less frequently associated with mortality, health systems and policy tend to be less responsive to 
these conditions and place lower importance on the development of policies and programmes to address them. This 
contributes to a general lack of population awareness concerning the burden an impact associated with MSK 
conditions.   Further, access to MSK healthcare is variable according to geography, ethnicity and socioeconomic status, 
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thus creating care disparities [102-106].  
Meso 
The meso level considers health services, the clinical workforce volume and competencies, health professional and 
student/trainee education, service delivery systems, funding models, and clinical infrastructure. Despite the identified 
burden of disease, the delivery of MSK care from practitioners and health systems inadequately aligns with best 
available evidence for what works [23, 25]. This may be attributed, in part, to deficiencies in knowledge and skills of 
health professionals, but is also largely influenced by funding and service models that inadequately support effective 
co-care. Access to, and delivery of, care is further complicated by the chronicity of MSK conditions and the high 
prevalence of comorbid conditions, particularly mental health conditions. 
Micro 
The micro level refers to the participation by the person in their care. The extent to which people participate in their 
care is largely dependent on their health literacy as it relates navigating the health system and MSK health. While all 
clinical guidelines recommend self-management by consumers, implicit in this expectation is that consumers have the 
knowledge and skills to do so. In many cases, this may not be the case, particularly for those people who live in 
socioeconomic disadvantage or in rural and remote settings. It is critical, therefore, for meso- and macro-level systems 
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